Cell Microsystems

BiotechnologySeries BDurham, UScellmicrosystems.com

Latest round

Series B

Last raised

Aug 2023

Total raised

$6.5M

Investors

1

About Cell Microsystems

Based in North Carolina, US, and founded in 2010 headed by Gary Pace (CEO), Cell Microsystems, Inc. is a biotechnology firm that helps the user of its tool to view, find and differentiate viable single cells and clonal colonies. The company’s customer base includes leading academic, government, and pharma organizations in the US and Europe. The firm across a range of single-cell methodologies provides multiple discovery and development applications through its products CellRaft AIR System and CytoSort consumables. Its application also includes single-cell isolation, CRISPR gene editing, and track and trace clonal propagation. Additionally, the firm also provides genomics, stem cell propagation and programming, and the development of novel cell lines and organoids.

Who invested in Cell Microsystems

1 investor across 1 round

See all investors in Cell Microsystems

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Aug 30, 2023

    Amount

    $6.5M

    Investors

    Locked

Questions about Cell Microsystems

Who invested in Cell Microsystems?

Cell Microsystems has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Cell Microsystems raised?

Cell Microsystems has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Cell Microsystems last raise money?

Cell Microsystems's most recent round on record is a Series B, in Aug 2023.

What does Cell Microsystems do?

Based in North Carolina, US, and founded in 2010 headed by Gary Pace (CEO), Cell Microsystems, Inc.

Where is Cell Microsystems headquartered?

Cell Microsystems is headquartered in Durham, US.

Which VCs invest in companies like Cell Microsystems?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cell Microsystems's stage. Their profiles are linked below.

Raising like Cell Microsystems? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.